Positive Interaction of Mangiferin With Selected Oral Hypoglycemic Drugs: A Therapeutic Strategy to Alleviate Diabetic Nephropathy in Experimental Rats
It represents a new class of therapies called triple agonists, meaning it simultaneously activates three key hormone receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon
This could also support alignment to a future focus in value-based care, by increasing ease of execution for risk-based agreements
nonetheless, adverse outcomes (e.g., diarrhea, nausea, vomiting, and decreased appetite, with dose-related effects) were observed [125]
Bypassing the Digestive System Transdermal patches provide a key advantage over oral pills by delivering ingredients directly into the bloodstream